February 15, 2022: Sinai Holdings LLC, a US based financial services firm that partners with companies developing innovative healthcare related technologies, has announced their investment into WoundClot, a next generation bleeding control product, developed and manufactured by Petah Tikvah, Israel based Core Scientific Creations Ltd.
Amnon Hamdani, CEO of Core Scientific Creations Ltd., says: "We’re excited to be able to announce our partnership with Sinai Holdings LLC. As a company well known for its work within the healthcare and biotechnology sector, Sinai Holdings has also established and operates medical treatment facilities specializing in areas like oncology, gastroenterology, and internal medicine. We feel like Sinai Holdings is a great fit and we are looking forward to a bright future and rapid growth with them."
According to the spokesperson for Sinai Holdings LLC, “WoundClot is revolutionizing the hemorrhage control market at all levels. The fact that it can stop any bleeding so rapidly and efficiently will change the way healthcare providers can save lives. This is, beyond any doubt, one of the most important investments we have ever made."
Sinai Holdings LLC is an US investment firm that has been investing in startup projects for more than 10 years, with an emphasis on unique and innovative technologies and products in the healthcare and biotechnology sectors. Sinai Holdings LLC has a global presence and has invested in companies and projects in over 10 countries. They specialize in identifying unique and innovative technologies in their early phases of development and move quickly to invest and assist these companies to grow. Sinai Holdings LLC is also involved in the acquisition and production of medical equipment and nutraceutical technologies and products.
For more information about WoundClot, please visit www.woundclotcsc.com
For more information about Sinai Holding LLC, please contact our public relations department: dbarak@percepto-digital.com.